Revisiting the IGF-1R as a breast cancer target

Abstract The type I insulin-like growth factor-1 receptor is a well-described target in breast cancer and multiple clinical trials examining insulin-like growth factor-1 receptor have been completed. Unfortunately, monoclonal antibodies and tyrosine kinase inhibitors targeting insulin-like growth fa...

Full description

Saved in:
Bibliographic Details
Main Authors: Roudy Chiminch Ekyalongo, Douglas Yee
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Online Access:https://doaj.org/article/ff753cb1f1364c4681fe4a6c2ca7b956
Tags: Add Tag
No Tags, Be the first to tag this record!